IRVINE, CA – 7 December 04 – Naturade, Inc. announced today that it has begun shipping a new line of four joint health products under the ReVivex™ brand name to meet the needs of consumers looking for fast results beyond what consumers have been able to achieve with Glucosamine and traditional supplements. The products are ReVivex™ Regular Strength, ReVivex™ Extra Strength, ReVivex™ PLUS and ReVivex™ Pain Relief Lotion.
According to Naturade CEO Bill Stewart, “ReVivex™ appeals to a 500% larger market than glucosamine-based products because it’s made with Celadrin®, a new, clinically tested ingredient. ReVivex™ works on muscles, tissues and tendons, unlike dietary supplements like glucosamine, chondroitin, MSM and SAMe that work primarily on joints.”
Clinical test results for Celadrin® published in the prestigious Journal of Rheumatology showed results in 30 days. The study showed additional benefits, even for people who already were taking other joint health products. With glucosamine, results can take six to eight weeks or longer.
“We’re overwhelmed with the positive response from major retailers including Wal-Mart, GNC, Albertsons, Fred Meyer, Pathmark, HEB, Brooks Pharmacy, Raleys, Whole Foods, Wild Oats and Longs Drug,” says Stewart. “We expect ReVivex™ to be on shelf in 10,000 retail stores in January when we launch our national consumer campaign.”
ReVivex™ with Celadrin® will be promoted on TV, radio and in magazines with hundreds of millions of media impressions to jump-start consumer recognition. Celadrin® is endorsed by Tony Gwynn, eight-time National League batting champion.
“ReVivex™ with Celadrin® is a breakthrough opportunity for retailers to bring in new business while meeting and exceeding the expectations of their joint health shoppers,” adds Stewart. “ReVivex™ with Celadrin® will revolutionize the joint health category the way that glucosamine did 10 years ago,” Products available for immediate shipment to retailers include the following: ReVivex™ Regular Strength: 40 easy-to-swallow dietary supplement tablets with 500 mg Celadrin®; Low out-of-pocket cost for initial trial; appeals to older/maintenance users.
ReVivex™ Extra Strength: 40 dietary supplement tablets with 50% more Celadrin® per tablet (750 mg); appeals to heavier users, offering lower cost per day.
ReVivex™ PLUS: 45 dietary supplement tablets with 500 mg Celadrin® for fast results plus 500 mg glucosamine to support long-term rebuilding and maintenance of cartilage.
ReVivex™ Pain Relief Lotion: This OTC drug includes pain-relieving menthol in an easy to use 1.5 fl oz pump bottle. It penetrates deeply to offer fast relief without the dry skin associated with many other topical analgesics.
Headquartered in Irvine, Calif., Naturade provides healthy solutions for weight loss consistent with its commitment – since 1926 – to improve the health and well being of consumers with innovative, natural products. Its premier product, Naturade Total Soy®, is a line of shake mix meal replacement products for weight loss and cholesterol reduction sold at major supermarket and club, health food, drug and mass merchandise stores throughout the U.S. and Canada. Well-known for over 50 years of leadership in soy protein, Naturade also markets a complete line of protein boosters for low carbohydrate dieters. The Company recently expanded further into the weight loss category with the Diet Lean™ line of natural supplements formulated with no stimulants or caffeine and into the sports nutrition category with the SportPharma® brand of products. Naturade’s other products include Calcium Shake™, Naturade Total Soy Menopause Relief™ and Power Shake®. For more information, visit: www.naturade.com
All statements in this press release that are not statements of historical fact are forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, marketing or sales, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. The risks and uncertainties include the following: the fact that our accountants have expressed doubt about our ability to continue as a going concern, our expectation of further losses, our need for additional financing and access to borrowing, changing consumer preferences for diet and nutritional products, our dependence on key customers, our dependence on third-party manufacturers, government regulations that could affect our products, our ability to identify suitable strategic partners, competition, our dependence on key personnel, labeling or promotion risks associated with the mass market, the effect of closely controlled stock, the pace of technological change, possible interruptions in our business resulting from the U.S. government’s response to terrorism, variability of quarterly results, product liability exposure, reduced sales in the dietary supplement industry, the effect of adverse publicity, our ability to protect our intellectual property, the rate of consumer acceptance of new product introductions, stock price volatility, and other risk factors that may be detailed from time to time in the company’s documents filed with the securities and exchange commission. Naturade does not undertake any obligation to update these forward-looking statements for actual results and future events, and does not intend to do so.
# # #
(714) 573-4800, ext. 221